权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Resilience and brain health of older adults during the COVID-19 pandemic

COVID-19 大流行期间老年人的复原力和大脑健康

基本信息

批准号：
10642836
负责人：
Breno Satler Diniz
金额：
$ 179.91万
依托单位：
WASHINGTON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-08-15 至 2026-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10642836
关键词：
Adult Age-associated memory impairment Aging Alzheimer&apos s Disease Alzheimer&apos s disease risk American Amyloid Amyloid beta-42 Amyloid beta-Protein Anxiety Atrophic Behavioral Biological Biological Aging Biological Markers Brain Buffers COVID-19 pandemic Clinical Clinical Trials Cognition Cognitive DNA Methylation Ecological momentary assessment Elderly Emotional Enrollment Episodic memory Exercise Exercise Test Functional Magnetic Resonance Imaging Funding Genotype Goals Health Health education Hippocampus Hydrocortisone Individual Intervention Knowledge Life Style Loneliness Magnetic Resonance Imaging Measures Medical Memory Mental Depression Methods Modeling Molecular Morbidity - disease rate Natural experiment Neurobiology Neuropsychology Outcome Participant Peripheral Personal Satisfaction Phase Phenotype Physiological Plasma Public Health Randomized Research Resources Rest SARS-CoV-2 exposure Salivary Social isolation Stress Structure Testing Time United States National Institutes of Health Well in self age effect aged brain health cognitive control cognitive function cognitive performance coping executive function follow-up high risk innovation intervention effect lifestyle intervention mindfulness mindfulness-based stress reduction negative affect neuroimaging novel pandemic disease pandemic impact pandemic stress post-pandemic prevent protective effect psychologic resilience risk variant satisfaction senescence sleep quality smartphone based assessment social social contact social engagement stress reduction stressor virtual

项目摘要

Abstract: Exercise and mindfulness are believed to be effective stress reduction interventions, but research to date has not been able to assess their benefits while individuals are coping with a major stressor in real time. The COVID-19 pandemic is an unwanted natural experiment in the deleterious effects of stress – especially social isolation (social disconnectedness and loneliness), a stressor particularly strongly associated with the pandemic - on older Americans’ cognitive and emotional health and risk for Alzheimer’s Disease (AD). This project will elucidate whether exercise and mindfulness can mitigate the effects of pandemic stress on cognitive function and emotional health in later life, including neurobiological measures of risk for AD. We will leverage a unique resource: the NIH-funded trial, “Mindfulness-Based Stress Reduction and Exercise for Age-Related Cognitive Decline” (MEDEX). By leveraging MEDEX and following these participants, who continue to attend monthly booster sessions of their randomized condition remotely during the pandemic, we will have repeated sets of clinical, cognitive, molecular, and neuroimaging measures covering 7.5 years during the pre-, during-, and post-pandemic period. We can examine intervention effects, as well as individual factors such as resilience, on long-term outcomes. Among other innovative aspects of the project, we will analyze effects on two novel peripheral biomarkers: Senescence-Associated Secretory Phenotype (SASP), which measures mechanisms of biological aging, and plasma amyloid Aβ42 and Aβ40, which measure AD risk. In the proposed project, (1) during the pandemic, we will use novel methods such as Ecological Momentary Assessment (EMA) to characterize social isolation both objectively (e.g., number of social contacts) and subjectively (e.g., loneliness), and its biological mechanisms on aging (such as elevations in SASP and plasma amyloid); (2) post-pandemic, we will assess downstream effects on cognitive function, emotional well-being, and brain health, including AD risk, using neuropsychological assessments, EMA, and neuroimaging. Outcomes include (Aim 1) changes in cognitive performance and emotional well-being, and decline in emotional well-being measured by positive and negative affect and sleep quality; increases in biological aging and decreasing AΒ42/40 ratio in the post-pandemic phase, indicating higher risk of AD; atrophy in hippocampal and prefrontal volume (structural MRI) and reduced global functional connectivity (resting-state fMRI). Modifiers of these effects (Aim 2) include exercise and mindfulness; psychological resilience; COVID-19 exposure; medical morbidities; and APOE genotype. Mechanisms of cognitive, emotional, and brain health changes (Aim 3) include amyloid (Aβ40 and Aβ42), SASP, DNA methylation, and cortisol during the pandemic. This project will advance our knowledge of the impact of social isolation and other stressors on older adults, including mechanisms by which these stressors produce deleterious cognitive, emotional, and brain health changes over time, and whether exercise and mindfulness have durable protective effects.

摘要：运动和正念被认为是有效的减压干预措施，但迄今为止的研究表明，当个人在真实的时间里应对一个主要的压力源时，不能评估它们的好处。的 2019冠状病毒病大流行是压力（尤其是社会压力）有害影响的一次不受欢迎的自然实验孤立（社会脱节和孤独），一个压力源，特别是强烈相关的大流行-对美国老年人的认知和情绪健康以及阿尔茨海默病（AD）的风险。这该项目将阐明锻炼和正念是否可以减轻流行病压力对晚年的认知功能和情绪健康，包括AD风险的神经生物学指标。我们将利用一个独特的资源：NIH资助的试验，“基于正念的减压和锻炼与抑郁症相关的认知能力下降（MEDEX）。通过利用MEDEX并跟踪这些参与者，在大流行期间，我们继续远程参加每月一次的随机病情强化会议，将在7.5年期间重复进行一系列临床、认知、分子和神经影像学测量，大流行前、大流行期间和大流行后的时期。我们可以检查干预效果，以及个人因素，例如复原力，对长期结果的影响。在该项目的其他创新方面，我们将分析对两种新的外周生物标志物的影响：衰老相关分泌表型（SASP），测量生物衰老机制以及测量AD风险的血浆淀粉样蛋白Aβ42和Aβ40。在拟议的项目中，（1）在大流行期间，我们将使用新的方法，如生态瞬间评估（EMA），以客观地表征社会隔离（例如，社会联系人的数量）和主观地（例如，孤独），以及它对衰老的生物学机制（如SASP和血浆中的升高），淀粉样蛋白）;（2）大流行后，我们将评估对认知功能，情绪健康，和大脑健康，包括AD风险，使用神经心理学评估，EMA和神经影像学。结果包括（目标1）认知表现和情感幸福感的变化，通过积极和消极的影响和睡眠质量来衡量情绪健康;生物衰老的增加在大流行后阶段，AΒ42/40比值降低，表明AD风险较高;海马萎缩，和前额叶体积（结构MRI）和减少的全球功能连接（静息态功能MRI）。这些效应的调节剂（目标2）包括锻炼和正念;心理弹性; COVID-19 暴露;医学发病率;和APOE基因型。认知、情绪和大脑健康的机制变化（目标3）包括大流行期间淀粉样蛋白（Aβ40和Aβ42）、SASP、DNA甲基化和皮质醇。这个项目将促进我们对社会孤立和其他压力因素对老年人的影响的认识，包括这些压力源产生有害的认知、情感和大脑健康的机制随着时间的推移而变化，以及运动和正念是否具有持久的保护作用。